Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
If you are thinking about NK cell therapy in Osaka, the first consultation is where a general interest becomes a concrete, personal discussion. Many international patients and residents in Japan arrive with questions but without the documents that make those questions easy to answer. This article explains what to prepare before a first visit to Grand Green Osaka Umekita Clinic, so that the time with the doctor is used well.
In short, the most helpful preparation is a clear summary of your diagnosis and current treatment, a list of your own questions, and realistic expectations about what an initial consultation can and cannot settle. Whether NK cell therapy is suitable for you is a decision that only a physician can make after examining your situation.
Why preparation matters for a first NK cell therapy consultation
NK (natural killer) cells are innate immune cells that patrol the body and can attack cancer cells and virus-infected cells. In NK cell therapy, NK cells obtained from a standard blood draw are activated and expanded at a specialized facility and then returned to the body by intravenous infusion. The treatment uses your own cells, which is one reason people ask about how it fits with the care they already receive.
Because the therapy is considered alongside, not instead of, standard cancer treatment such as surgery, chemotherapy or radiation therapy, the doctor needs to understand what you are already receiving. A consultation that starts with accurate information is more likely to end with answers that are specific to you, rather than general descriptions.
It is also worth remembering that this is a self-pay medical service. It is not covered by public health insurance in Japan, so the discussion naturally includes costs, the number of sessions and the overall schedule, as well as risks and possible side effects.
Medical information worth gathering before you visit
Doctors in Japan will usually find it easier to advise you when they can see a coherent picture of your medical history. If you are being treated abroad, ask your current care team for copies of the following, ideally in English or with a translation:
- A summary of your diagnosis, including the type and stage of cancer and the date of diagnosis.
- A list of treatments you have received so far and those that are planned, with dates.
- Recent blood test results and imaging reports, if your oncologist is willing to share them.
- A current medication list, including supplements, and any known allergies.
- The name and contact details of your treating oncologist, in case coordination is needed.
Not every document will be available, and an initial consultation can still take place with partial information. However, the more complete your records are, the easier it becomes for the doctor to discuss whether and how NK cell therapy might be considered. Please bring only what you are comfortable sharing, and ask how your personal information will be handled.
Questions to write down before the appointment
It is easy to forget questions in the room, especially when you are discussing a serious illness in a second language. Writing them down in advance helps. Some questions that patients commonly find useful include the following:
- Based on my situation, is NK cell therapy something that could reasonably be considered, and what would you want to assess first?
- How would it be timed around my surgery, chemotherapy or radiation therapy?
- What are the possible side effects and risks, and what happens if I feel unwell after an infusion?
- What does the evidence say, and what remains uncertain? What are the limits of this therapy?
- What are the fees, how many sessions are usually proposed, and over what period?
- How are the cells processed, and under what legal framework is the treatment provided?
A thoughtful physician should be comfortable with questions about limits and uncertainty. NK cell therapy research is ongoing, and no responsible explanation can promise a particular result. If an answer sounds like a guarantee, that is a good reason to ask more questions.
How regulation, cost and logistics fit into the conversation
In Japan, cell therapies of this kind are provided under the Act on the Safety of Regenerative Medicine, which requires a provision plan to be submitted to and accepted by the national authorities, and cells to be processed at a licensed facility. It is reasonable to ask the clinic to explain how this applies to the treatment you are considering and how quality and safety are managed.
Because treatment is self-pay, ask for a written explanation of the fees and what they include. Also ask about the practical side: how many visits to Osaka would be needed, how long each visit takes, and how the schedule could be arranged around your standard care. For visitors from abroad, these details often decide whether a plan is feasible at all.
Please note that specific amounts, schedules and eligibility are confirmed by the doctor at the time of consultation, and the information on a website or in an article like this one should not be treated as a substitute for that discussion.
Language support and next steps at Grand Green Osaka Umekita Clinic
Grand Green Osaka Umekita Clinic is located in Umeda, Osaka, and offers an information page for international patients in English, along with options to make contact through the website or LINE. If you need interpretation or have questions about documents from overseas, it is sensible to mention this when you make an appointment so that arrangements can be considered in advance.
Before you go, check that you have your records, your list of questions, and the contact details of your own oncologist. After the consultation, take time to review what you have heard, and consider discussing it with the doctor who is treating you at home. NK cell therapy is one option to understand carefully, and any decision should be made with a physician, with attention to your safety, your standard treatment and your own priorities.
This article is for general information and is not medical advice. Please consult a qualified physician about your individual circumstances.
- 1Gather your recordsDiagnosis and treatment summary
- 2Write your questionsRisks, fees, evidence
- 3Share your current careStandard treatment plans
- 4Consult the doctorSuitability is decided there
This diagram is a conceptual summary of the article's content
References
- PubMed: Natural killer cell-based immunotherapy for cancer. (2025)
- PubMed: CAR-NK cells: A promising cellular immunotherapy for cancer. (2020)
- PubMed: Emerging trends in clinical allogeneic CAR cell therapy. (2025)
- PubMed: CAR-NK cell therapy: promise and challenges in solid tumors. (2025)
- PubMed: Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity. (2018)
- PMC: Adoptive immunotherapy against ovarian cancer. (2016)
- PMC: Current progress in NK cell biology and NK cell-based cancer immunotherapy. (2020)
- PMC: Natural Killer Cell Recognition and Control of Epithelial Cancers. (2022)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.